A detailed history of Cullen/Frost Bankers, Inc. transactions in Health Catalyst, Inc. stock. As of the latest transaction made, Cullen/Frost Bankers, Inc. holds 1,119 shares of HCAT stock, worth $4,028. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,119
Previous 980 14.18%
Holding current value
$4,028
Previous $6,000 16.67%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 02, 2025

BUY
$3.97 - $7.42 $551 - $1,031
139 Added 14.18%
1,119 $5,000
Q4 2024

Feb 06, 2025

BUY
$6.9 - $9.02 $779 - $1,019
113 Added 13.03%
980 $6,000
Q3 2024

Nov 06, 2024

BUY
$5.48 - $8.83 $745 - $1,200
136 Added 18.6%
867 $7,000
Q2 2024

Aug 05, 2024

BUY
$5.53 - $7.28 $4,042 - $5,321
731 New
731 $4,000

Others Institutions Holding HCAT

About Health Catalyst, Inc.


  • Ticker HCAT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 54,723,400
  • Market Cap $197M
  • Description
  • Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accura...
More about HCAT
Track This Portfolio

Track Cullen/Frost Bankers, Inc. Portfolio

Follow Cullen/Frost Bankers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullen/Frost Bankers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cullen/Frost Bankers, Inc. with notifications on news.